(PharmaNewsWire.Com, June 26, 2019 ) Factors such as the rising geriatric population, increase in the volume of surgeries and sports-related injuries, and increasing awareness about the medical implications of adhesions are expected to drive adhesion barrier market growth during the forecast period. The untapped emerging markets are expected to present growth opportunities for players in the market.
North America accounted for the largest share of the adhesion barrier market in 2018, followed by Europe. Increase in the incidence of chronic diseases associated with aging population, increase in the volume of surgical procedures, well-established healthcare services, and higher public and private healthcare expenditure are responsible for the largest share of North America in the adhesion barriers market.
The adhesion barrier market is expected to reach USD 1,064 million by 2027 from an estimated USD 610 million in 2019, at a CAGR of 7.2%.
The hyaluronic acid segment is projected to witness the highest growth during the forecast period
Based on the type, the synthetic adhesion barrier market is further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol (PEG), and other synthetic adhesion barriers (such as combination products of polyethylene oxide and carboxymethylcellulose, icodextrin, silicone rubber, expanded polytetrafluorethylene (ePTFE) membrane, and hydrogel). The hyaluronic acid segment is expected to grow at the highest CAGR during the forecast period. Growth in this market is driven by the growing preference for hyaluronic acid-based adhesion barriers among surgeons.
The gel formulation is expected to grow at the highest CAGR during the forecast period
On the basis of formulations, the adhesion barrier market is segmented into film, liquid, and gel formulations. During the forecast period, the gel formulations segment is expected to grow at the highest CAGR. Growth in this segment is due to the growth in the demand and preference for gel-form adhesion barriers among end users.
The neurological surgeries segment is expected to register the highest CAGR during the forecast period
Based on applications, the adhesion barriers market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The neurological surgeries segment is estimated to register the highest CAGR during the forecast period. The growth of this segment is driven by the increasing focus of players on developing adhesion barrier gels for neurological surgeries.
Asia Pacific to witness the highest growth during the forecast period
Asia Pacific is expected to witness the highest growth during the forecast period (2018 to 2023). The region’s large geriatric population, large patient population, improving healthcare infrastructure, growing medical tourism, and epidemiological shift from infectious to chronic diseases are driving the growth of this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
